Consistent top sales performer w/ contract, field trainer and supervi
Resume:
PAUL A. CAPUTO
***************@*****.***
SUMMARY
Award Winning Sales Professional with extensive experience in the medical industry promoting technical products to office based and hospital based clinicians as well as pharmacy and nursing staff. Proven ability to consistently exceed sales goals, learn new skill sets or therapeutic classes, readily engage the providers and their staff; rapidly gain their trust and close the sale. Accomplished IDN, large account representative, promoting products for both sales and contracting, injectable/buy and bill as well as providing detailed GPO contracting/ reimbursement information. Promoted therapeutic classes include Oncology, Hematology, Rheumatology, Car- diology, Anesthesia, Neurology, Pain, CNS, Women’s Health, Infectious Disease, Gastroenterology, En- docrinology.
PROFESSIONAL EXPERIENCE
SCILEX HOLDING 12/2022-Present
Territory Business Manager
Promote ZTLido, Elyxyb and Gloperba to Pain Specialists, Neurologists and Rheumatologists
• Currently Ranked #1 in the nation Ztlido
• Ranked 7 nationally on 6vs6 growth
• 303% to goal for Elyxyb, 118% to goal for ZTLido EISAI INC
Oncology Sales Specialist 3/2020-1/2022(Downsized) Promote Lenvima in combination with Keytruda for advanced Endometrial Carcinoma as well as Lenvima first line for HCC, DTC and Halaven third line for metastatic breast cancer.
• 123.03% to goal current quarter Lenvima 106% Halaven
• 137% to goal pervious quarter
• 2020 LTI award winner
• Ranked #13 nationally 2020
• 2nd in the nation for % growth/growth over baseline Q3
• Achieved 241% of goal Q3
• 119.94% of target 2020
EUSA PHARMA/Syneos
Key Account Manager 1/2019-12/2019(Downsized)
Launch of only FDA approved monoclonal antibody Sylvant to treat ultra rare Castleman’s disease.
• Developed a network of KOL’s to help patients get on therapy faster
• Liaison between rare disease network and company to advance patient coverage
(developing centers of excellence, enlisting practices, enhancing research through patient samples) MT PHARMA AMERICA/Syneos 6/2017- 1/2019
Neuroscience Account Specialist
Launch of first FDA approved drug for the treatment of ALS in 22 years to Neurologist, IDN’s, institutions as well as stand alone and home infusion centers.
• Over 3000 cartons shipped to territory since launch
• Formulary obtainment at all targeted accounts
• Recruited and enrolled infusion centers to allow smother transition of care SANDOZ 3-/2015-3/2017(Downsized)
Key Account Manager, Oncology
Contract management of first FDA approved biosimilar, Zarxio to targeted cancer treatment hospitals, teaching institutions, clinics and private practices throughout the state.
• Responsible for converting 33 accounts; top 5% nationally EMERGENT BIOSOLUTIONS 12/2013-3/2015
Oncology Specialist
Promote WinRho/Episil/Hepagam B to oncologist and hematologist in key accounts
• Q1 152.8% quota attainment, 2014 ranked #1 nationally
• 85.74% growth current quarter vs. prior quarter
• Product Sales Champion Q1, 2014
• Q2 137% quota attainment, 2014 ranked #3 nationally
• Q3 winner national sales award
OPTIMER PHARMACEUTICALS 4/2013-12/2013(Downsized)
Hospital Account Manager
Promote Dificid with-in key areas of targeted hospital
• 50.36% increase in sales from Q1 to Q2 (157% goal attainment)
• Winner of the Q2 tier up contest
• Product formulary placement in key accounts
• 1st place national award as part of the district for greatest growth SUNOVION PHARMACEUTICALS INC. 6/2011- 3/2013(Downsized) Therapeutic Specialist
Promote Sunovions line of CNS products to key specialists in office based and account setting.
• 2012 Presidents Circle of Excellence Award Winner (top 5%)
• Finished Q1 ranked #3 in the Region #9 in the Nation, 104.64% of Quota
• Finished Q3 ranked #15 in the Region top 25% Nationally,
• Finished Q4 ranked #2 in the Region #12 in the Nation, 105.4% of Quota BOEHRINGER INGELHEIM 6/2010-6/2011
Institutional Specialist
Promote Pradaxa, Spiriva, Tradjenta and Aggrenox with-in key areas of the hospital.
• Last ranking 3rd in the region and 12th in the nation (top 10%)
• Platinum Award recipient
• Obtained early formulary acceptance at all accounts
• 300% of goal for Q1& Q2
• Product hospital protocol in place at key accounts SCHERING-PLOUGH/ORGANON INC. 7/2006 – 3/2010(Downsized) Executive Territory Manager/Hospital Division
Promoted Integrilin and Avelox in the Cath Lab and other key departments within the hospital setting. Prior drugs include Zemuron, Anzemet and Implanon.
Integrilin
• Ranked # 1 in District for both products for Q4.
• Ranked #1 in the district current C4W vs. P4W
• Turned around underperforming territory
Zemuron
• Converted single largest volume account in district (Geisinger Medical Center) from Cistatracurium to Zemuron.
• 9th in the nation goal attainment Q1.
• Increased territories contribution to region from 76% to 107% over the course of the year.
• Scrubbed in on over 100 cases.
Executive Territory Manager/ District Trainer 4/2001-7/2006 Specialty sales Remeron Soltab, Avinza and Nuvaring to psychiatrists, pain specialists, rheumatologists and OB/ GYN’s, completed supervisor training
• Regional High Achiever 2006 (Top 10%)
• District TM of the year 2006
• High Performance Award 2006
• Regional High Achiever 2005 (top 10%)
• District TM of the year 2005
• High Performance Award 2005
• Region A Action Award winner 2005
• Region A Action Award Q2 2005
• Cigna pull through contest winner 2005
• CPN contest winner Q3 2005
• Regional High Achiever 2004 (top 10%)
• Regional Representative of the month 2002
• On Leader Board consistently for growth/ MS increase EDUCATION
Bachelor of Science, Management, Clemson University, Clemson, SC HONORS
Full athletic scholarship Clemson University, Football, Atlantic Coast Conference champions, Hall of Fame Bowl champions, Citrus Bowl Champions, Gator Bowl champions, Coca Cola Bowl champions, Four year letterman
TECHNICAL SKILLS
Word, Excel, PowerPoint, Outlook
Contact this candidate